CMV neurologic disease

Revision as of 14:52, 13 July 2016 by Rossdonaldson1 (talk | contribs) (Text replacement - "==Clinical Presentation==" to "==Clinical Features==")

Background

Clinical Features

Differential Diagnosis

Diagnosis

Management

Antivirals

  • Ganciclovir 5mg/kg IV q12hrs x 21 days then 5mg/kg IV q24hrs +
    • Foscarnet 90mg/kg IV q12hrs x 21 days then 90-120mg/kg IV q24hrs

Disposition

See Also

External Links

References